Untargeted molecular tests are increasingly available for diagnosis of infectious diseases. In this national survey, plasma metagenomic next-generation sequencing had widespread use (89.8%), but disparate frequency from a few times ever (18.4%) to > weekly (9.... ...

请注册登录后继续浏览